Abstract
This paper aims to highlight the relevance of the quality of management in the well-being of a firm and its influence on market valuation. The study which is based on the Indian Pharmaceutical Industry, measures and employs the quality of Management and directorship, together with the Return on Capital Employed (ROCE), to assess the influence on market valuation and the efficiency of assets employed. The study employs forty companies that are listed on the Bombay Stock Exchange, for a period of 12 years from the fiscal year 2008-09 to 2019-20. Through Path Analysis, it is established that ROCE, Quality of management, and Directorship in that order influence the market valuation which is represented by the Q ratio. ROCE & Dividends impact the efficiency of assets under use, which is represented by the Asset Turnover Ratio (ATO).
 
 Received: 03 October 2022 / Accepted: 23 December 2022 / Published: 5 January 2023
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
